Combat tuberculosis (TB)

By Oxford Immunotec

In order to assist the World Health Organisation’s (WHO’s) ‘End TB Strategy’ with the goal of reducing the global incidence of tuberculosis by 80% in 2030, detecting latent TB infection (LTBI) is key. From the province of Reggio Emilia, Italy, Dr Edoardo Carretto discusses the role of Oxford Immunotec’s T-SPOT.TB test in tackling cases of LTBI to help eradicate TB in the province.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.